Abstract Library

#3812 Validation of NEP-D score as a prognostic index in bronchial carcinoid tumors

Introduction: The development of prognostic scores able to classify patients with Bronchial Carcinoid (BC) according to clinical outcomes may help guide treatment selection. The NEP- score was found to be useful to stratify survival probability in patients with well-differentiated neuroendocrine neoplasms (NENs). According to multiple factors (age, primary tumor site, presence of metastasis, Ki-67, presence of functioning status and prior surgical removal of the primary tumor) NEP- score stratifies patients into different risk groups. The NEP-score at diagnosis (NEP-D score) is a derived score that could be calculated at diagnosis and does not consider the appearance of new metastases during follow-up.

Conference:

Presenting Author:

Authors: Medici M, Gagliardi I, Zanata I, Borges de Souza P, Ambrosio M,

Keywords: Bronchial Carcinoid, Neuroendocrine neoplasm, NEP-Score, Prognosis, Survival,

#3772 R-ache-L score – A nomogram model for predicting prognosis of lung neuroendocrine tumors according to primary tumor side

Introduction: The prognosis of atypical carcinoids (AC) is worse than that of typical carcinoids (TC). Molecular analyses have suggested a more heterogeneous disease for the first ones. However, no previous study has established an individualized predictive model for the prognosis of lung neuroendocrine tumos (Lu-NETs) considering the location of the primary tumor in the right versus left lung parenchyma.

Conference:

Presenting Author: La Salvia A

Authors: La Salvia A, Marcozzi B, Manai C, Mazzilli R, Pallocca M,

Keywords: Lung neuroendocrine tumor, Tumor location (left vs right parenchyma), Prognostic factor, Nomogram, R-ache-L Prognostic Score,

#1748 External Validation of Prognostic Classification Score for Predicting Overall Survival (OS) of Patients (pts) with Advanced Well Differentiated Neuroendocrine Tumour (WDNET). Neuroendocrine European Prognostic Score (NEP Score Working Group)

Introduction: Absence of relevant prognostic score (PS) in NET

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Pusceddu S

Authors: Pusceddu S, Barretta F, Botta L, Trama A, Milione M,

Keywords: neuroendocrine, prognostic score,

#1492 Prospective Validation of Prognostic Score in High-Grade Gastrointestinal Neuroendocrine Carcinomas (GI-NECs)

Introduction: Prognostic markers for risk-stratification of GI-NECs are lacking.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Lamarca A

Authors: Lamarca A, Barriuso J, McNamara M, Hubner R, Valle J,

Keywords: NEC, score, overall survival, high grade, prognostic,

#1420 A New Immunohistochemistry Prognostic Score (IPS) Based on MGMT, NDRG-1 and PHLDA-3 for Recurrence and Survival in Resected Pancreatic Neuroendocrine Tumors (PanNET)

Introduction: In PanNET tumors contradictory data about the prognostic role of MGMT (O6-methylguanine DNA methyltransferase) has been published. NDRG-1 (N-myc downstream-regulated gen-1) and PHLDA-3 (Pleckstrin homology-like domain family A member 3) immunohistochemistry (IHC) expressions have been evaluated in several solid malignant tumors, but their roles in PanNET remain unknown

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Viudez A

Authors: Viudez A, Carvalho F, Maleki Z, Zahurak M, Laheru D,

Keywords: Pancreatic Neuroendocrine Tumor, MGMT, NDRG-1, PHLDA-3,